Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines

Heterologous “prime-boost” regimens that involve priming with plasmid DNA vaccines and boosting with recombinant viral vectors have been shown to elicit potent virus-specific cytotoxic T-lymphocyte responses. Increasing evidence, however, suggests that the utility of recombinant viral vectors in hum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barouch, Dan H., McKay, Paul F., Sumida, Shawn M., Santra, Sampa, Jackson, Shawn S., Gorgone, Darci A., Lifton, Michelle A., Chakrabarti, Bimal K., Xu, Ling, Nabel, Gary J., Letvin, Norman L.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2003
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC167238/
https://ncbi.nlm.nih.gov/pubmed/12885892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.77.16.8729-8735.2003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars